Equities

Lipigon Pharmaceuticals AB

Lipigon Pharmaceuticals AB

Actions
  • Price (SEK)0.33
  • Today's Change0.00 / 0.00%
  • Shares traded724.18k
  • 1 Year change-37.02%
  • Beta--
Data delayed at least 15 minutes, as of Apr 22 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • LPGO:STO price moved over +9.14% to 0.37
  • LPGO:STO price reached a new 52-week low of 0.281 at 13:59 BST
  • LPGO:STO trading volume exceeds daily average by +24.22%
  • LPGO:STO price rises above 15-day moving average to 0.3195 at 16:25 BST

Key statistics

As of last trade, Lipigon Pharmaceuticals AB (LPGO:STO) traded at 0.33, 26.92% above the 52 week low of 0.26 set on Apr 19, 2024.
52-week range
Today
0.26Apr 19 20240.82Sep 20 2023
Open0.339
High0.374
Low0.32
Bid0.32
Offer0.3295
Previous close0.33
Average volume344.31k
Shares outstanding126.42m
Free float89.03m
P/E (TTM)--
Market cap41.72m SEK
EPS (TTM)-0.3229
SEK
Data delayed at least 15 minutes, as of Apr 22 2024 17:00 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.